Abstract
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in rheumatoid arthritis (RA) patients. Guidelines of the American College of Cardiology and the American Heart Association (ACC/AHA) 2013 and the Adult Treatment Panel III (ATP-III) differ in their strategies to recommend initiation of statin therapy. The presence of carotid plaque (CP) by carotid ultrasound is an indication to begin statin therapy. We aimed to compare the recommendation to initiate statin therapy according to the ACC/AHA 2013 guidelines, ATP-III guidelines, and CP by carotid ultrasound. We then carried out an observational, cross-sectional study of 62 statin-naive Mexican mestizo RA patients, aged 40 to 75, who fulfilled the 1987 or 2010 ACR/European League Against Rheumatism (EULAR) classification criteria. CP was evaluated with B-mode ultrasound. Cohen’s kappa (k) was used to assess agreement between ACC/AHA 2013 guidelines, ATP-III guidelines, and the presence of CP, considering a p < 0.05 as statistically significant. Agreement was classified as slight (0.01–0.20), fair (0.21–0.40), moderate (0.41–0.60), substantial (0.61–0.80), and an almost perfect agreement (0.81–1.00). Slight agreement (k = 0.096) was found when comparing statin recommendation between CP and ATP-III. Fair agreement (k = 0.242) was revealed between ACC/AHA 2013 and ATP-III. Comparison between ACC/AHA 2013 and CP showed moderate agreement (k = 0.438). ACC/AHA 2013 guidelines could be an adequate and cost-effective tool to evaluate the need of statin therapy in Mexican mestizo RA patients, with moderate agreement with the presence of CP by ultrasound.
Similar content being viewed by others
References
You S, Cho CS, Lee I, Hood L, Hwang D, Kim WU (2012) A systems approach to rheumatoid arthritis. PLoS One 7:e51508
Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307
Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA (2011) Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Res Ther 13:R101
Solomon DH, Greenberg J, Curtis JR, Liu M, Farkouh ME, Tsao P et al (2015) Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study. Arthritis Rheum 67:1995–2003
Arts EE, Popa C, Den Broeder AA, Semb AG, Toms T, Kitas GD et al (2015) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 74:668–674
Danninger K, Hoppe UC, Pieringer H (2014) Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? Int J Rheum Dis 17:606–611
Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331
Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH et al (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380:581–590
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497
Andrus B, Lacaille D (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 63:2886
Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M (2014) Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology 53:2143–2154
Gonzalez-Gay MA, Gonzalez-Juanatey C (2014) Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis 73:1281–1283
Kasliwal RR, Bansal M, Desai D, Sharma M (2014) Carotid intima-media thickness: current evidence, practices, and Indian experience. Indian J Endocrinol Metab 18:13–22
Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA (2009) Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 38:366–371
Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O et al (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217:3–46
Guardado-Estrada M, Juarez-Torres E, Medina-Martinez I, Wegier A, Macias A, Gomez G et al (2009) A great diversity of Amerindian mitochondrial DNA ancestry is present in the Mexican mestizo population. J Hum Genet 54:695–705
Park HW, Kim WH, Kim KH, Yang DJ, Kim JH, Song IG et al (2013) Carotid plaque is associated with increased cardiac mortality in patients with coronary artery disease. Int J Cardiol 166:658–663
Tahmasebpour HR, Buckley AR, Cooperberg PL, Fix CH (2005) Sonographic examination of the carotid arteries. RadioGraphics 25:1561–1575
Gisev N, Bell JS, Chen T (2013) Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Adm Pharm 9:330–338
Pecina MJ, Navar-Boggan AM, D’Agostino RB, Williams K, Neely B, Sniderman AD et al (2014) Application of new cholesterol guidelines to a population-based sample. N Engl J Med 370:1422–1431
Aguilar-Salinas CA, Gomez-Perez FJ, Rull J, Villalpando S, Barquera S, Rojas R (2010) Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 52:44–53
Alcocer LA, Lozada O, Fanghänel G, Sanchez-Reyes L, Campos-Franco E (2011) Estratificación del riesgo cardiovascular global. Comparación de los métodos Framingham y SCORE en población mexicana del estudio PRIT. Cir Cir 79:168–174
Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-Diaz C, Anaya JM, Rojas-Villarraga A (2012) Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America. Arthritis 2012:371909
Saba L, Anzidei M, Sanfilippo R, Montisci R, Lucatelli P, Catalano C et al (2012) Imaging of the carotid artery. Atherosclerosis 220:94–309
Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA (2002) MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol 22:1065–1074
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written consent was obtained from all participants according to local ethical committee.
Disclosures
None.
Rights and permissions
About this article
Cite this article
Galarza-Delgado, D.A., Azpiri-Lopez, J.R., Colunga-Pedraza, I.J. et al. Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis. Clin Rheumatol 35, 2823–2827 (2016). https://doi.org/10.1007/s10067-016-3312-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3312-z